(Q62110335)

English

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

clinical trial

Statements

A Phase IA Trial of Combined Murine IgG Monoclonal Anti-Transferrin Receptor Antibodies E2.3 and A27.15 in Cancer Patients (English)
0 references
0 references
0 references
0 references
0 references
0 references
December 1997
0 references
February 2001
0 references
27
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit